Today: 27 June 2026
Record Highs, $55 B Deals & Data Drama: Wall Street’s Wild Week (Oct 4–5, 2025)
17 November 2025
3 mins read

IPO Week Nov 17–21, 2025: Excelsoft & Gallard Steel to open on Nov 19; PhysicsWallah, Emmvee, Tenneco, Fujiyama & Capillary set to list

Dateline: Monday, November 17, 2025

India’s primary market enters a quieter stretch this week, but action isn’t absent. Only two fresh IPOs—Excelsoft Technologies (mainboard) and Gallard Steel (SME)—will open for subscription on Wednesday, November 19, while seven companies are slated to list between Tuesday and Friday, keeping traders focused on debut-day price discovery.


Quick highlights for today

  • Two issues to open this week (Nov 19–21):
    Excelsoft Technologies (₹500 crore; price band ₹114–₹120) — mainboard.
    Gallard Steel (₹37.5 crore; price band ₹142–₹150) — BSE SME.
  • Seven listings on the bourses this week:
    Nov 18 (Tue): PhysicsWallah, Emmvee Photovoltaic Power
    Nov 19 (Wed): Tenneco Clean Air India
    Nov 20 (Thu): Fujiyama Power Systems
    Nov 21 (Fri): Capillary Technologies India
    SME (Nov 18): Workmates Core2Cloud Solution, Mahamaya Lifesciences.
  • Tone of the week: After a busy run of mainboard and SME deals, the IPO pipeline narrows, with Excelsoft the marquee name.

What opens for subscription this week (Nov 19–21)

Excelsoft Technologies IPO (Mainboard)

  • Issue size & structure: ₹500 crore, comprising a fresh issue of ₹180 crore and an offer for sale (OFS) of ₹320 crore by promoter Pedanta Technologies. Price band: ₹114–₹120. Lot size: 125 shares.
  • Use of proceeds: Capital spend on a new Mysuru facility (about ₹62 crore), upgrades to the existing unit (about ₹39.5 crore), IT infrastructure (about ₹54.6 crore), and general corporate purposes. Proposed to list on BSE and NSE; Anand Rathi Advisors is the sole book-running lead manager.
  • Business snapshot: A vertical SaaS player in learning and assessment serving clients across multiple geographies; reported FY25 revenue of ~₹233.3 crore and profit of ~₹34.7 crore.

Gallard Steel IPO (BSE SME)

  • Issue window & size: Opens Nov 19, closes Nov 21; ₹37.5 crore (fresh issue only). Price band: ₹142–₹150. Retail minimum: 2,000 shares. Planned listing on the BSE SME platform.
  • Use of proceeds: Expansion capex, construction of office building, partial debt repayment, and general corporate needs.
  • What it makes: Engineered steel castings for sectors including Indian Railways, defence and power.

IPO listings to watch this week

  • Tuesday, Nov 18:
    PhysicsWallah (edtech) and Emmvee Photovoltaic Power (solar PV manufacturer) debut after subscription levels of 1.81× and 0.97×, respectively.
  • Wednesday, Nov 19:
    Tenneco Clean Air India lists after a blockbuster 58.83× subscription.
  • Thursday, Nov 20:
    Fujiyama Power Systems begins trading; its public issue closes today (Nov 17).
  • Friday, Nov 21:
    Capillary Technologies India lists a day after bidding closes (Nov 18).
  • SME on Tuesday, Nov 18:
    Workmates Core2Cloud Solution and Mahamaya Lifesciences list on BSE SME.

Grey market check (informal): Over the weekend, observers indicated the steepest premium in the unofficial market for Tenneco (25%+), with PhysicsWallah and Capillary in the mid‑single digits; Fujiyama and Emmvee had little to no premium. GMP is unregulated and highly volatile—treat purely as sentiment, not valuation.


Why this week is lighter—and what it means

Market chatter points to a “quiet IPO week” as issuers space out launches after a hectic run of mainboard and SME offerings. That leaves Excelsoft in the spotlight among fresh issues, with multiple recent IPOs still commanding attention via their listings. For investors and traders, price discovery shifts from bidding to debut-day action. The Economic Times


Key dates at a glance (Nov 17–21, 2025)

  • Nov 17 (Mon): Fujiyama Power Systems bidding ends; Capillary Technologies India continues (ends Nov 18).
  • Nov 18 (Tue): Listings—PhysicsWallah, Emmvee Photovoltaic Power; SME listings—Workmates Core2Cloud Solution, Mahamaya Lifesciences.
  • Nov 19 (Wed): Excelsoft & Gallard Steel open; Tenneco Clean Air India lists.
  • Nov 20 (Thu): Fujiyama Power Systems lists.
  • Nov 21 (Fri): Excelsoft & Gallard Steel close; Capillary Technologies India lists.

What to watch before applying (general guidance)

  • Price band & lot size: Excelsoft at ₹114–₹120 (lot: 125 shares); Gallard Steel at ₹142–₹150 (retail minimum: 2,000 shares). Check the RHP for final details and risk factors.
  • Use of funds & governance: Excelsoft’s capex and IT investments are central to its plan; Gallard’s proceeds go to expansion and partial deleveraging.
  • Listing-day dynamics: Seven debuts this week can absorb attention and liquidity—especially the high‑interest Tenneco, which saw strong demand during bidding.

The bottom line

For Monday, November 17, 2025, India’s IPO calendar features two subscriptions opening mid‑week and seven market debuts across mainboard and SME segments. Investors tracking the primary market will likely focus on Excelsoft’s fundamentals and pricing, while traders watch listing‑day moves in PhysicsWallah, Emmvee, Tenneco, Fujiyama, Capillary and the SME names.

This report is for information only and is not investment advice. Please read the Red Herring Prospectus (RHP), risk factors, and consult a qualified advisor before investing.

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Stock Market Today

  • Rocket Lab Faces Profit Delays and Neutron Setbacks, Weighing on Stock
    June 27, 2026, 1:53 PM EDT. Rocket Lab's (RKLB) road to profitability faces hurdles, with the company's earnings not expected before 2028. Delays in the Neutron rocket, a key project, add to investor concerns. These factors combine to fuel a bearish outlook on RKLB stock as the aerospace firm's challenges mount.

Latest articles

Verizon (NYSE:VZ) spectrum outlay grabs focus after Dow drop

Verizon (NYSE:VZ) spectrum outlay grabs focus after Dow drop

27 June 2026
Verizon surged 2.6% last week to $46.54 as investors digested its $3.16 billion spend on 82 AWS-3 spectrum licenses—about 1.6% of its market value and equal to a quarter’s dividend payout—while heavy trading followed news that Alphabet will replace Verizon in the Dow before Monday’s open.
IRS tax preparer fraud case draws investor attention to 75 million paid returns

IRS tax preparer fraud case draws investor attention to 75 million paid returns

27 June 2026
The Supreme Court let stand a ruling allowing the IRS unlimited time to assess taxes on returns tainted by preparer fraud, even if the taxpayer was unaware, spotlighting risk for 75 million paid-preparer e-filed returns and raising the stakes for firms like H&R Block and Intuit as investors watch the growing share and complexity of assisted tax filings.
US equities this week: AI chip slide grabs focus as rest of market holds up

US equities this week: AI chip slide grabs focus as rest of market holds up

27 June 2026
Investors yanked nearly $20 billion from technology funds in the week to June 24, reversing last week’s record inflows, as the PHLX semiconductor index plunged 7.9% for its worst week since April, raising fresh questions about AI profits and capital spending while S&P 500 and Nasdaq posted sharp weekly declines. (Reuters)
Vistra Corp (VST) Stock News Today: Institutional Flows, Q3 Earnings and 2026 Outlook – 16 November 2025
Previous Story

Vistra Corp (VST) Stock News Today: Institutional Flows, Q3 Earnings and 2026 Outlook – 16 November 2025

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover
Next Story

Novo Nordisk Slashes Wegovy and Ozempic Cash Prices to $349, Launches $199 Intro Deals as GLP‑1 Price War Escalates

Go toTop